Skip to main content
European Commission logo
IP Helpdesk
News article30 May 20221 min read

Out Now: New Factsheet Tackling IP in the Pharma & Healthcare Sectors in India

Dropping a brand-new factsheet, the India IP SME Helpdesk team aims to offer EU SMEs general guidelines on how to protect and manage their intellectual property in India when operating in the pharmaceutical and healthcare sectors.

India has gained a reputation as the world’s biggest pharmacy, being a centre of manufacturing to a large part of the world’s drugs and medical equipment. In India as in the rest of the world, the pharma and healthcare sectors are some of the most highly regulated markets, which require regulatory approvals before any drug can be put on the market. The approvals from the Central Government’ agencies as well as relevant agencies of the respective State Governments are essential. The key regulatory bodies that issue marketing authorisations are the Central Drugs Standard Control Organisation (CDSCO), Director General of Health Services (DGHS), Drugs Technical Advisory Board (DTAB), International Coalition of Medicines Regulatory Authorities (ICMRA), etc.




Publication date
30 May 2022